These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 17241386

  • 1. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
    Tamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M.
    Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
    Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA.
    Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330
    [Abstract] [Full Text] [Related]

  • 3. Recurrence of primary sclerosing cholangitis in patients after liver transplantation.
    Ołdakowska-Jedynak U, Nowak M, Mucha K, Foroncewicz B, Nyckowski P, Zieniewicz K, Ziarkiewicz-Wróblewska B, Patkowski W, Górnicka B, Paczkowska A, Michałowicz B, Pilecki T, Pawlak J, Krawczyk M, Paczek L.
    Transplant Proc; 2006 Nov; 38(1):240-3. PubMed ID: 16504713
    [Abstract] [Full Text] [Related]

  • 4. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report.
    Oya H, Sato Y, Yamamoto S, Takeishi T, Kobayashi T, Hatakeyama K.
    Transplant Proc; 2004 Oct; 36(8):2297-8. PubMed ID: 15561226
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
    Maheshwari A, Yoo HY, Thuluvath PJ.
    Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
    [Abstract] [Full Text] [Related]

  • 10. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S.
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [Abstract] [Full Text] [Related]

  • 11. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
    Morioka D, Egawa H, Kasahara M, Jo T, Sakamoto S, Ogura Y, Haga H, Takada Y, Shimada H, Tanaka K.
    Liver Transpl; 2007 Jan; 13(1):80-90. PubMed ID: 16964594
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased?
    Graziadei IW.
    Curr Opin Gastroenterol; 2011 May; 27(3):301-5. PubMed ID: 21248637
    [Abstract] [Full Text] [Related]

  • 16. Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.
    Miyagawa-Hayashino A, Egawa H, Yoshizawa A, Ueda Y, Ichida T, Ueno Y, Uemoto S, Harada K, Nakanuma Y.
    Hum Pathol; 2011 Sep; 42(9):1329-36. PubMed ID: 21334714
    [Abstract] [Full Text] [Related]

  • 17. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
    Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT.
    Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
    [Abstract] [Full Text] [Related]

  • 18. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 19. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL.
    Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
    Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M.
    J Gastrointest Surg; 2009 Aug; 13(8):1480-6. PubMed ID: 19430850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.